NCT00635401View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

August 31, 2004

Conditions
Smoking
Interventions
DRUG

Varenicline

0.5 mg BID for 7 weeks

Trial Locations (8)

Unknown

Pfizer Investigational Site, Chuo-ku Fukuoka

Pfizer Investigational Site, Nishi-ku Yokohama

Pfizer Investigational Site, Beppu

Pfizer Investigational Site, Ōita

Pfizer Investigational Site, Hamamatsu

Pfizer Investigational Site, Edogawa-ku

Pfizer Investigational Site, Minato-ku

Pfizer Investigational Site, Toshima-ku

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00635401 - A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking | Biotech Hunter | Biotech Hunter